1012 related articles for article (PubMed ID: 30321484)
21. LncRNA FRMD6-AS1/miR-491-5p/USP13 pathway attenuated ferroptosis and contributed to liver fibrosis.
Li Z; Zou W; Jin X; Wang Y
Environ Toxicol; 2024 Jun; 39(6):3760-3771. PubMed ID: 38558500
[TBL] [Abstract][Full Text] [Related]
22. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
23. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells.
Zhang F; Zhang Z; Chen L; Kong D; Zhang X; Lu C; Lu Y; Zheng S
J Cell Mol Med; 2014 Jul; 18(7):1392-406. PubMed ID: 24779927
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol.
Zheng Y; Wang L; Wang J; Zhao T; Wang J
Curr Med Chem; 2024; 31(19):2821-2837. PubMed ID: 38351696
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.
Li JP; Gao Y; Chu SF; Zhang Z; Xia CY; Mou Z; Song XY; He WB; Guo XF; Chen NH
Acta Pharmacol Sin; 2014 Aug; 35(8):1031-44. PubMed ID: 24976156
[TBL] [Abstract][Full Text] [Related]
26. Oroxylin A induces apoptosis of activated hepatic stellate cells through endoplasmic reticulum stress.
Bian M; He J; Jin H; Lian N; Shao J; Guo Q; Wang S; Zhang F; Zheng S
Apoptosis; 2019 Dec; 24(11-12):905-920. PubMed ID: 31538267
[TBL] [Abstract][Full Text] [Related]
27. Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studies.
Kong D; Zhang F; Wei D; Zhu X; Zhang X; Chen L; Lu Y; Zheng S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1223-33. PubMed ID: 23425217
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.
Kim KH; Lee JM; Zhou Y; Harpavat S; Moore DD
Mol Endocrinol; 2016 Aug; 30(8):905-16. PubMed ID: 27355192
[TBL] [Abstract][Full Text] [Related]
29. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
[TBL] [Abstract][Full Text] [Related]
30. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
31. Silencing p53 inhibits interleukin 10-induced activated hepatic stellate cell senescence and fibrotic degradation in vivo.
Guo Q; Chen M; Chen Q; Xiao G; Chen Z; Wang X; Huang Y
Exp Biol Med (Maywood); 2021 Feb; 246(4):447-458. PubMed ID: 33028080
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury.
Du K; Oh SH; Dutta RK; Sun T; Yang WH; Chi JT; Diehl AM
Liver Int; 2021 Sep; 41(9):2214-2227. PubMed ID: 33991158
[TBL] [Abstract][Full Text] [Related]
33. Calcium channel blockers ameliorate iron overload-associated hepatic fibrosis by altering iron transport and stellate cell apoptosis.
Zhang Y; Zhao X; Chang Y; Zhang Y; Chu X; Zhang X; Liu Z; Guo H; Wang N; Gao Y; Zhang J; Chu L
Toxicol Appl Pharmacol; 2016 Jun; 301():50-60. PubMed ID: 27095094
[TBL] [Abstract][Full Text] [Related]
34. Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis.
Cho SS; Yang JH; Lee JH; Baek JS; Ku SK; Cho IJ; Kim KM; Ki SH
Free Radic Biol Med; 2022 Nov; 193(Pt 2):620-637. PubMed ID: 36370962
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation.
Yu Y; Sun X; Gu J; Yu C; Wen Y; Gao Y; Xia Q; Kong X
Int J Biol Sci; 2016; 12(10):1225-1235. PubMed ID: 27766037
[TBL] [Abstract][Full Text] [Related]
36. SENP2 alleviates CCl
Bu FT; Chen Y; Yu HX; Chen X; Yang Y; Pan XY; Wang Q; Wu YT; Huang C; Meng XM; Li J
Toxicol Lett; 2018 Jun; 289():86-98. PubMed ID: 29535048
[TBL] [Abstract][Full Text] [Related]
37. Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.
Zhang Z; Zhao S; Yao Z; Wang L; Shao J; Chen A; Zhang F; Zheng S
Redox Biol; 2017 Apr; 11():322-334. PubMed ID: 28038427
[TBL] [Abstract][Full Text] [Related]
38. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis.
Chatani N; Kamada Y; Kizu T; Ogura S; Furuta K; Egawa M; Hamano M; Ezaki H; Kiso S; Shimono A; Ouchi N; Yoshida Y; Takehara T
Liver Int; 2015 Aug; 35(8):2017-26. PubMed ID: 25488180
[TBL] [Abstract][Full Text] [Related]
39. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
40. A novel STAT3 inhibitor, STX-0119, attenuates liver fibrosis by inactivating hepatic stellate cells in mice.
Choi S; Jung HJ; Kim MW; Kang JH; Shin D; Jang YS; Yoon YS; Oh SH
Biochem Biophys Res Commun; 2019 May; 513(1):49-55. PubMed ID: 30935693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]